Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
Income Tax Expense
$0.00
Quarterly · Period ending: · USD
LCTX Income Tax Expense
Latest reported$0.00period ending
Latest reported$0.00period ending
LCTX Quarterly Income Tax ($100.00K → $0.00)
Quarterly income tax expense
High-resolution chart · PNG
LCTX income tax expense history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Income Tax Expense (USD) |
|---|---|
| 0 | |
| 0 | |
| -5,280,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -1,803,000 | |
| 0 | |
| 541,000 | |
| 0 | |
| 0 | |
| 1,181,000 | |
| -1,012,000 | |
| -169,000 | |
| 0 | |
| -1,061,000 | |
| -178,000 | |
| 0 | |
| 0 | |
| -784,000 | |
| -991,000 | |
| -1,248,000 | |
| -4,384,000 | |
| -346,000 | |
| 0 | |
| 0 | |
| 0 | |
| -4,772,000 | |
| 4,772,000 | |
| -3,877,000 | |
| 3,877,000 | |
| -14,007,000 | |
| 0 | |
| 0 | |
| 0 | |
| -1,121,000 | |
| -948,000 | |
| -1,271,000 | |
| -1,176,882 | |
| -2,200,634 | |
| -2,312,693 | |
| -1,513,258 | |
| -1,349,026 | |
| 25,236,403 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -1,005,859 | |
| -703,823 | |
| -615,103 | |
| -94,708 | |
| -487,574 | |
| -732,636 | |
| -827,951 | |
| -1,065,862 | |
| 4,556,806 | |
| -17,485 | |
| -14,155 | |
| -27,950 | |
| -26,500 | |
| -3,638 | |
| -2,136 | |
| 596,937 | |
| 0 | |
| 0 | |
| 0 | |
| 280,908 | |
| 0 | |
| 0 | |
| 0 | |
| 35,931 | |
| 0 | |
| 26,664 | |
| 0 | |
| -23,138 | |
| 0 | |
| 15,560 | |
| 1,064 | |
| -51,321 | |
| 49,518 | |
| 0 | |
| 0 | |
| -99,448 | |
| 0 | |
| 2,520 | |
| 80,000 | |
| 167,478 | |
| 261,267 | |
| 65,908 | |
| 171,665 | |
| 189,048 | |
| -30,722 |